To refer to this page use:
|Abstract:||This commentary summarizes the historical landscape of short-acting CHC trials as it relates to the emerging role of obesity not only as an important factor in the outcomes of contemporary CHC trials but as a key issue to be considered by potential users and prescribers seeking the most appropriate contraceptive method for each individual woman.|
|Citation:||Edelman, Alison, Trussell, James, Aiken, Abigail RA, Portman, David J, Chiodo, Joseph A, Garner, Elizabeth IO. (2018). The emerging role of obesity in short-acting hormonal contraceptive effectiveness.. Contraception, 97 (5), 371 - 377. doi:10.1016/j.contraception.2017.12.012|
|Pages:||1 - 12|
|Type of Material:||Journal Article|
|Version:||Final published version. Article is made available in OAR by the publisher's permission or policy.|
Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.